Loading
Loading…
Loading…
Eligibility, documents, scope, Go/No-Go checksEligibility, required documents, scope of work and Go/No-Go checks for this tender, in one click.
Tender Value
Refer Docs
EMD Value
₹75,000
Closing Date
30 Oct 2026, 3:00 pm
Eligibility, documents, scope, Go/No-Go checksEligibility, required documents, scope of work and Go/No-Go checks for this tender, in one click.
Additional Commisioner
PMC Office, Panvel
as per tender
2026_PMC_1343932_1
PMC/MOH/01/2026-27
Open Tender
Medicines
Item Rate
365 days
PMC Area
as per tender
3 documents required · 3 mandatory
₹1,180
₹75,000
Online
13 Oct 2026
13 Oct 2026
2 Nov 2026
13 Oct 2026
30 Oct 2026
13 Oct 2026
15 Oct 2026
| Sl No | Description | Qty | Unit | Est. Rate | Est. Amount |
|---|---|---|---|---|---|
| 1LIST OF REQUIRED ITEM | |||||
| 1.01 | AMOXYCILLINE 500 MG | 2,50,000 | 1 CAP | 1 | ₹2,50,000 |
| 1.02 | CLOFAZIME 100MG | 850 | 1 CAP | 2 | ₹1,700 |
| 1.03 | DOMPERIDONE 10 MG + OMPRAZOLE 20 MG | 30,000 | 1 CAP | 3 | ₹90,000 |
| 1.04 | DOXYCILINE 100MG | 3,00,000 | 1 CAP | 4 | ₹12,00,000 |
| 1.05 | ITRACONAZOLE 100 MG BP | 35,872 | 1 CAP | 5 | ₹1,79,360 |
| 1.06 | LOPRAMIDE 2 MG | 25,000 | 1 CAP | 6 | ₹1,50,000 |
| 1.07 | METHYLCOBALAMIN, ALPHA LIPOIC ACID, BENFOTHIAMINE, PYRIDOXINE, FOLIC ACID & CHROMIUM | 60,000 | 1 CAP | 7 | ₹4,20,000 |
| 1.08 | NIFEDIPINE 5 MG | 9,684 | 1 CAP | 8 | ₹77,472 |
| 1.09 | OSELTAMIVIR 75 MG | 50,000 | 1 CAP | 9 | ₹4,50,000 |
Tap a document below to read it instantly. You can also download everything as a ZIP if you prefer.
details.html
html • 0.03 MB
Tendernotice_1.pdf
PDF • 0.22 MB
TENDER_MEDICINE.pdf
Tender Documents • 0.96 MB
BOQ_2296951.xls
BOQ • 0.38 MB
Download all tender documents and submit your bid
Disclaimer: TenderKart has made every reasonable effort to ensure that the information on this page is accurate and authentic, however it cannot be held liable for any third-party claims or losses or any damages. TenderKart makes no warranty, expressed or implied, as to the results obtained from the use of this information. If you notice any error or omission, please let us know at .